Cite
MLA Citation
Tommy A. Brown et al.. “Final analysis of a phase I/IIa trial of the folate‐binding protein‐derived E39 peptide vaccine to prevent recurrence in ovarian and endometrial cancer patients.” Cancer medicine, vol. 8, n.d., pp. 4678–4687. http://access.bl.uk/ark:/81055/vdc_100091289199.0x000013